PEG-Asparaginase is a PEGylated form of L-Asparaginase
PEGylation increases enzyme half-life
Lower allergic reactions compared to native L-Asparaginase
Manufactured under stringent GMP conditions to ensure consistent potency
Product application
• Clinical and preclinical studies in oncology • Research and development in biopharmaceuticals • Pharmaceutical formulations for acute lymphoblastic leukemia (ALL) treatment
Connect to Explore More
PEG-Asparaginase is a PEGylated form of L-Asparaginase, an enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL). The PEGylation enhances stability, prolongs half-life, and reduces immunogenicity, making it a preferred choice for therapeutic applications.
Why Choose Us?
Lorven Biologics Private Limited specializes in the development and large-scale production of high-quality therapeutic enzymes. With a strong commitment to innovation and compliance, we ensure reliable and cost-effective bulk supply solutions for global partners.
Key features & Benefits
Enhanced Stability: PEGylation increases enzyme half-life and reduces degradation.
Reduced Immunogenicity: Lower allergic reactions compared to native L-Asparaginase.
High Purity & Activity: Manufactured under stringent GMP conditions to ensure consistent potency.
Extended Circulation Time: Allows for reduced dosing frequency in therapeutic applications.
Reliable Bulk Supply: Scalable production to meet global pharmaceutical and biopharma needs.
Specifications
• PEGylation: Site-specific PEG modification
• Specific Activity: ≥ 85 IU/mg
• Endotoxin Level: ≤ 50 EU/mL
• Storage: 2–8°C or -20°C for long-term stability
Compliance & Quality Assurance
• Manufactured in cGMP-compliant facilities
• Stringent quality control and batch-to-batch consistency
• Regulatory support available for global market approvals
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.
PEG-Asparaginase is a PEGylated form of L-Asparaginase
PEGylation increases enzyme half-life
Lower allergic reactions compared to native L-Asparaginase
Manufactured under stringent GMP conditions to ensure consistent potency
Product application
• Clinical and preclinical studies in oncology • Research and development in biopharmaceuticals • Pharmaceutical formulations for acute lymphoblastic leukemia (ALL) treatment
Connect to Explore More
PEG-Asparaginase is a PEGylated form of L-Asparaginase, an enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL). The PEGylation enhances stability, prolongs half-life, and reduces immunogenicity, making it a preferred choice for therapeutic applications.
Why Choose Us?
Lorven Biologics Private Limited specializes in the development and large-scale production of high-quality therapeutic enzymes. With a strong commitment to innovation and compliance, we ensure reliable and cost-effective bulk supply solutions for global partners.
Key features & Benefits
Enhanced Stability: PEGylation increases enzyme half-life and reduces degradation.
Reduced Immunogenicity: Lower allergic reactions compared to native L-Asparaginase.
High Purity & Activity: Manufactured under stringent GMP conditions to ensure consistent potency.
Extended Circulation Time: Allows for reduced dosing frequency in therapeutic applications.
Reliable Bulk Supply: Scalable production to meet global pharmaceutical and biopharma needs.
Specifications
• PEGylation: Site-specific PEG modification
• Specific Activity: ≥ 85 IU/mg
• Endotoxin Level: ≤ 50 EU/mL
• Storage: 2–8°C or -20°C for long-term stability
Compliance & Quality Assurance
• Manufactured in cGMP-compliant facilities
• Stringent quality control and batch-to-batch consistency
• Regulatory support available for global market approvals
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.
PEG-Asparaginase is a PEGylated form of L-Asparaginase
PEGylation increases enzyme half-life
Lower allergic reactions compared to native L-Asparaginase
Manufactured under stringent GMP conditions to ensure consistent potency
Product application
• Clinical and preclinical studies in oncology • Research and development in biopharmaceuticals • Pharmaceutical formulations for acute lymphoblastic leukemia (ALL) treatment
Connect to Explore More
PEG-Asparaginase is a PEGylated form of L-Asparaginase, an enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL). The PEGylation enhances stability, prolongs half-life, and reduces immunogenicity, making it a preferred choice for therapeutic applications.
Why Choose Us?
Lorven Biologics Private Limited specializes in the development and large-scale production of high-quality therapeutic enzymes. With a strong commitment to innovation and compliance, we ensure reliable and cost-effective bulk supply solutions for global partners.
Key features & Benefits
Enhanced Stability: PEGylation increases enzyme half-life and reduces degradation.
Reduced Immunogenicity: Lower allergic reactions compared to native L-Asparaginase.
High Purity & Activity: Manufactured under stringent GMP conditions to ensure consistent potency.
Extended Circulation Time: Allows for reduced dosing frequency in therapeutic applications.
Reliable Bulk Supply: Scalable production to meet global pharmaceutical and biopharma needs.
Specifications
• PEGylation: Site-specific PEG modification
• Specific Activity: ≥ 85 IU/mg
• Endotoxin Level: ≤ 50 EU/mL
• Storage: 2–8°C or -20°C for long-term stability
Compliance & Quality Assurance
• Manufactured in cGMP-compliant facilities
• Stringent quality control and batch-to-batch consistency
• Regulatory support available for global market approvals
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.